• New study points to a strategy for inhibiting hyper-progression of melanoma

    2 days ago - By News Medical

    Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.
    Read more ...